1. Home
  2. ALXO vs YYGH Comparison

ALXO vs YYGH Comparison

Compare ALXO & YYGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • YYGH
  • Stock Information
  • Founded
  • ALXO 2015
  • YYGH 2010
  • Country
  • ALXO United States
  • YYGH Singapore
  • Employees
  • ALXO N/A
  • YYGH N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • YYGH
  • Sector
  • ALXO Health Care
  • YYGH
  • Exchange
  • ALXO Nasdaq
  • YYGH NYSE
  • Market Cap
  • ALXO 76.5M
  • YYGH 69.2M
  • IPO Year
  • ALXO 2020
  • YYGH 2024
  • Fundamental
  • Price
  • ALXO $0.66
  • YYGH $1.76
  • Analyst Decision
  • ALXO Strong Buy
  • YYGH
  • Analyst Count
  • ALXO 6
  • YYGH 0
  • Target Price
  • ALXO $4.14
  • YYGH N/A
  • AVG Volume (30 Days)
  • ALXO 1.4M
  • YYGH 25.6K
  • Earning Date
  • ALXO 03-06-2025
  • YYGH 04-08-2025
  • Dividend Yield
  • ALXO N/A
  • YYGH N/A
  • EPS Growth
  • ALXO N/A
  • YYGH 527.44
  • EPS
  • ALXO N/A
  • YYGH 0.04
  • Revenue
  • ALXO N/A
  • YYGH $37,372,731.00
  • Revenue This Year
  • ALXO N/A
  • YYGH N/A
  • Revenue Next Year
  • ALXO N/A
  • YYGH N/A
  • P/E Ratio
  • ALXO N/A
  • YYGH $43.76
  • Revenue Growth
  • ALXO N/A
  • YYGH 55.18
  • 52 Week Low
  • ALXO $0.65
  • YYGH $0.72
  • 52 Week High
  • ALXO $17.83
  • YYGH $4.70
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 33.23
  • YYGH N/A
  • Support Level
  • ALXO $0.65
  • YYGH N/A
  • Resistance Level
  • ALXO $0.74
  • YYGH N/A
  • Average True Range (ATR)
  • ALXO 0.07
  • YYGH 0.00
  • MACD
  • ALXO -0.00
  • YYGH 0.00
  • Stochastic Oscillator
  • ALXO 0.54
  • YYGH 0.00

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About YYGH YY GROUP HOLDING LIMITED

YY Group Holding Ltd is a data and technology driven company focused on developing enterprise intelligent labor matching services and smart cleaning services founded in Singapore. It provides enterprise manpower outsourcing and smart cleaning services in Singapore and Malaysia. The group has two operating segment, which is cleaning services segment and manpower outsourcing services, Maximum revenue is generated from cleaning services.

Share on Social Networks: